A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: events (609), actions (832), measures (541), trial (517), procedures (653), dealings (63), minutes (1000)

HSCTAlemtuzumabBusulphan-08-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (8 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-8-Fludarabine-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (12 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabBusulphan-10-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (10 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-10-Fludarabine-VUD-Methotrexate-GvHD.pdf

HSCTCyclophosphamideTBI_Related_Methotrexate_GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)-METHOTREXATE (GvHD) Related Donor Conditioning This regimen will only be available
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTCyclophosphamideTBI-Related-Methotrexate-GvHD.pdf

HSCTAlemtuzumabCyclophosphamideTBI_VUD_Methotrexate_GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) Conditioning This regimen will
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabCyclophosphamideTBI-VUD-Methotrexate-GvHD.pdf

Procedure for bioimpedance using the Seca mBCA

Description
NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system for the writing
Url
/Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-bioimpedance-using-the-Seca-mBCA.pdf

Institutional information_2022-23_final

Description
Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document being submitted for differe
Url
/Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2022-23-final.pdf

Institutional information_2021_final

Description
Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document being submitted for differe
Url
/Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2021-final.pdf

Handling concerns and complaints policy

Description
Handling Complaints Policy, Version 13.0 Trust reference PET003 Version number 13.0 Description Policy to explain how
Url
/Media/UHS-website-2019/Docs/Policies/Handling-concerns-and-complaints-policy.pdf

Isatuximab VRD weekly

Description
Chemotherapy Protocol Myeloma Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20) Regimen Myeloma – Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Isatuximab-VRD-weekly-Ver1.pdf
81 to 90 of 100
Previous … 6 7 8 9 10 Next